The Current Ratio as of December 2025 (TTM) for Frontage Holdings Corporation (1521.HK) is 1.24

According to Frontage Holdings Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.24. This represents a change of -3.90% compared to the average of 1.29 of the last 4 quarters.

Frontage Holdings Corporation (1521.HK) Historical Current Ratio (quarterly & annually)

How has 1521.HK Current Ratio performed in the past?

The mean historical Current Ratio of Frontage Holdings Corporation over the last ten years is 2.82. The current 1.24 Current Ratio has changed 4.31% with respect to the historical average. Over the past ten years (40 quarters), 1521.HK's Current Ratio was at its highest in in the June 2019 quarter at 8.44. The Current Ratio was at its lowest in in the January 2016 quarter at 0.

Frontage Holdings Corporation (1521.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Frontage Holdings Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Frontage Holdings Corporation (1521.HK) Average Current Ratio

How has 1521.HK Current Ratio performed in the past?

The current Current Ratio of Frontage Holdings Corporation (1521.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Frontage Holdings Corporation (1521.HK) Current Ratio vs. Peers

How is 1521.HK’s Current Ratio compared to its peers?

Frontage Holdings Corporation’s Current Ratio is less than Cutia Therapeutics (3.16), less than HighTide Therapeutics Inc (3.44), greater than SinoMab BioScience Limited (0.87), greater than Mabpharm Limited (1.07), less than Shanghai Bio-heart Biological Technology Co., Ltd. (12.65), greater than Clover Biopharmaceuticals, Ltd. (0.26), less than Shanghai Pioneer Holding Ltd (4.70), less than JBM (Healthcare) Limited (2.91), greater than Immunotech Biopharm Ltd (0.08), less than Essex Bio-Technology Limited (1.90),

Build a custom stock screener for Frontage Holdings Corporation (1521.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frontage Holdings Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Frontage Holdings Corporation (1521.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Frontage Holdings Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.